ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Acadia Pharmaceuticals Inc

Acadia Pharmaceuticals Inc (0A4W)

0.00
0.00
( 0.00% )

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 17.33M124.9M223.81M339.08M441.76M484.15M517.24M726.44M
Operating Income -272.82M-292.41M-247.44M-246.55M-286.59M-170.44M-223.6M-73.38M
Pre Tax Income -270.05M-288.28M-243.94M-234.38M-280.97M-167.52M-213.44M-51.04M
Net Income -271.39M-289.4M-245.19M-235.26M-281.58M-167.87M-215.98M-61.29M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -2.236-2.326-1.704-1.515-1.764-1.043-1.333-0.373
EBIT -272.82M-292.41M-247.44M-246.55M-286.59M-170.44M-223.6M-73.38M
EBITDA -270.99M-289.7M-244.44M-243.78M-283.65M-167.1M-221.57M-67.83M

Your Recent History

Delayed Upgrade Clock